Microdose protocols (lower starting doses with gradual titration) may allow the gastrointestinal system to adapt with fewer acute side effects, though clinical data on this strategy is still emerging
Start Your GLP-1 Weight Loss Journey Today Success requires more than just medication
If future research continues to support the heart and kidney benefits seen in current trials, GLP-1 medicines could become part of a broader strategy aimed not only at managing disease but potentially delaying some of its most serious consequences
As mentioned earlier, GLP-1 RAs function similarly to statins by inhibiting HMG-CoA reductase, suggesting that GLP-1 RAs can be prescribed as not only an antidiabetic medication but also as a cholesterol-lowering medication that can reduce the prevalence of CVD [64,65,70-73]
Specifically, patients were randomized in an open-label fashion to receive either: (i) PIO 30 mg/day for 2 weeks followed by PIO 45 mg/day for 50 weeks ( n = 10) or (ii) EXE 5 g twice daily and PIO 30 mg/day for 2 weeks followed by EXE 10 g twice daily and PIO 45 mg/day for 50 weeks ( n = 11)
Eat well